Bandaram Pharma Packtech passes all five resolutions at FY26 AGM
- All five resolutions passed unanimously at Bandaram Pharma's FY26 AGM
- Total votes polled stood at 13,560,514 with zero votes against
- Public shareholder voting participation remained low at approximately 34%

*this image is generated using AI for illustrative purposes only.
Bandaram Pharma Packtech Limited concluded its Annual General Meeting for FY26 on September 24, 2026, with all five proposed resolutions passed unanimously. The meeting, held via video conference, saw a total of 37 members participate electronically.
The agenda included the adoption of audited standalone and consolidated financial statements for the year ended March 31, 2026. Members also approved the reappointment of Mr. Bhandaram Premasai Reddy as a director retiring by rotation and the reappointment of M/s. M.M. Reddy & Co. as statutory auditors.
Special business approved
A special resolution was passed regarding the reappointment of Mr. Suryaprakasa Rao Bommisetti as an Independent Director. The company disclosed that promoters and promoter group members had an interest in this specific resolution.
Voting participation details
Voting results indicated high promoter participation and moderate public engagement. Promoters voted on 100% of their holding, while non-institutional public shareholders voted on approximately 34.26% of their holding. No votes were cast against any resolution.
| Resolution Type | Votes Polled | Votes in Favour | Votes Against | Result |
|---|---|---|---|---|
| Ordinary (Financials) | 13,560,514 | 13,560,514 | 0 | Passed |
| Ordinary (Director Reappt.) | 13,560,514 | 13,560,514 | 0 | Passed |
| Special (Ind. Dir. Reappt.) | 13,560,514 | 13,560,514 | 0 | Passed |
What the Numbers Show
The voting data reveals a significant divergence in shareholder engagement between promoter groups and public investors. While promoters cast votes on 100% of their 11,262,084 shares, non-institutional public shareholders participated on only 2,298,430 out of 6,709,239 shares held. This results in a public participation rate of roughly 34%, compared to full participation from the promoter group, highlighting a concentration of voting power among insiders.
Historical Stock Returns for Bandaram Pharma Packtech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.01% | +3.71% | +16.57% | -20.46% | -34.70% | -8.19% |
How might the 34% public shareholder participation rate impact Bandaram Pharma Packtech's future corporate governance ratings and institutional investor confidence?
What specific strategic initiatives or capital expenditure plans were outlined in the FY26 financial statements that could drive growth in the upcoming fiscal year?
Given the unanimous approval and lack of dissenting votes, how will the company address potential regulatory scrutiny regarding the concentration of voting power among promoters?
































